Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial
about
Amisulpride versus other atypical antipsychotics for schizophreniaPharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature reviewA translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacyPlasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trialsTreatment-resistant Schizophrenia: Evidence-based StrategiesAssociation between antipsychotic/antidepressant drug treatments and hospital admissions in schizophrenia assessed using a mental health case registerAugmenting amisulpride with clozapine had led to unmasking of akathisia.Pharmacotherapy for treatment-refractory schizophrenia.Antipsychotic polypharmacy in schizophrenia: benefits and risks.Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.Pharmacological approaches to the management of schizophrenia: 10 years on.The practical management of refractory schizophrenia--the Maudsley Treatment REview and Assessment Team service approach.Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.Antipsychotic combinations for schizophrenia.Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.Ziprasidone as adjunctive therapy in severe bipolar patients treated with clozapine.Update on the management of symptoms in schizophrenia: focus on amisulpride.Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study.Clozapine augmentation with amisulpride.Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.Augmentation of clozapine with a second antipsychotic - a meta-analysis.Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial.
P2860
Q24240433-E2364D5E-A34A-47AE-A280-82A9981A1711Q24598636-B4431C8F-F5DA-40D5-BAAB-3DD732B0390EQ30485065-EFE74AB9-07F2-4EF6-BB10-059363F0C19CQ34418688-25E9FC00-41B9-4AD5-8666-94F9D9D90032Q34640811-460C6E84-03E1-4432-A8FB-01C146ED2C94Q34925151-84C3545C-C496-4673-920B-A578D494F187Q35964353-81BABE5F-36A8-4D63-A932-D2987BCFEB75Q36848311-1E57A6EA-6C84-403A-94B4-59F1316B84EBQ37314248-D7A3F8B0-BC64-4777-A41F-F2173BCAFD7EQ37831352-CEB362B8-A71F-4D2C-A664-749423508BC4Q37863093-48090C5D-4EA5-41AD-87B2-D3B7AE420367Q38081872-D05DC164-0F7B-46D8-A1F0-6FDC84D49FBAQ38101540-0EB08A66-D029-4EFE-8FBE-F249C72C9E56Q38247122-309024AA-3D53-496D-A6FA-05222A5FB8E9Q38256894-36514D12-0BBC-4B48-BFB8-D33620B99FD4Q38704394-91A9C23A-9A7A-4770-BE50-E28097C8B30EQ38741061-45CD9514-69F2-4C2D-A9F8-AB0FEE9BE48AQ39037156-4B6B5448-A79C-402C-8F1B-A9B22C755DC7Q41529086-24884427-CE51-4751-815B-69A7569EDE24Q42395373-9F429660-CED5-4214-B596-B950DDA88CBAQ42969381-6F0341F5-8796-485B-8A0D-C9609CA671C5Q47152270-6241CE76-AF3A-4352-B40B-E44D7F7F86A4Q50674482-12931D00-4F01-4C55-BD8C-830C66B4B0BBQ53091132-C0C06202-1EDA-4678-8C67-A5BC1F00017FQ55423236-0D48B0A3-056A-41D3-9BD8-BAAEE38A50B7
P2860
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@ast
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@en
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@nl
type
label
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@ast
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@en
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@nl
prefLabel
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@ast
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@en
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@nl
P2093
P3181
P356
P1433
P1476
Amisulpride augmentation in pa ...... lind, placebo-controlled trial
@en
P2093
H Reinbold
H-J Assion
M Basilowski
S Lemanski
P3181
P356
10.1055/S-2007-993209
P407
P577
2008-01-01T00:00:00Z